{
    "clinical_study": {
        "@rank": "23241", 
        "acronym": "3G", 
        "arm_group": [
            {
                "arm_group_label": "Low gluten", 
                "arm_group_type": "Active Comparator", 
                "description": "Poor gluten diet: Participants consume less than 5g gluten per day (estimated to correspond to a gluten intake below the 10th percentile in the population)"
            }, 
            {
                "arm_group_label": "High gluten", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Refined grain/ gluten rich diet : Participants consume more than 25g of gluten per day (estimated to correspond to a gluten intake around the 90th percentile in the population)"
            }
        ], 
        "brief_summary": {
            "textblock": "Objective: To identify how specific changes of the gluten content in the diet affect the\n      host-gut microbiome interactions with implications for metabolic health.\n\n      Design: A randomized, controlled, single-blinded, cross-over intervention trial consisting\n      of two 8-week interventions periods, separated by a 6-week wash-out period. A total number\n      of 60 participants will be included.\n\n      Intervention: low vs high gluten intake."
        }, 
        "brief_title": "The Effect of Gluten on Gut Microbiome and Metabolic Health.", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Metabolic Diseases", 
            "Injury of Gastrointestinal Tract"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Metabolic Diseases", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study is designed as a randomized, controlled, single-blinded, cross-over intervention\n      trial consisting of two 8-week interventions periods, separated by a 6-week wash-out period.\n      A total number of 60 participants will be included. Participants consume, in randomized\n      order, a gluten-poor diet (<5 g/d) in the active treatment period and a gluten-rich diet\n      (>25 g/d) during the control period.\n\n      Measurements: Altered quantitative metagenomics at bacterial gene- and species levels is the\n      primary outcome of this study. Secondary outcomes include metabolic and inflammatory\n      markers, circulating appetite hormone levels,serum metabolomics, gastrointestinal transit\n      time and intestinal permeability. Furthermore, selected control measures are included; 4-day\n      food records and a study intervention dietary records."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria, compulsory:\n\n          -  Body mass index (BMI):  25 - 35 kg/m2 OR\n\n          -  Abdominal obesity: waist circumference: men: \u2265 94cm; women: \u2265 80cm\n\n          -  No medically prescribed diet\n\n          -  Weight stable\n\n          -  Intense sporting activities less than 10 h/week\n\n          -  Alcohol consumption less than 14 units/week (female)  and 21 units/week (male)\n\n          -  Signed informed consent\n\n        Inclusion criteria, minimum one of the following:\n\n          -  Fasting plasma glucose from 6.1 mmol/l  to 6.9 mmol/l\n\n          -  Reduced high density lipoprotein (HDL) cholesterol;  HDL \u2264 1.03 mmol/L for men and \u2264\n             1.29 mmol/L for women\n\n          -  Increased triglyceride (TG) > 1.3 mmol/L\n\n          -  Systolic blood pressure > 130 mmHg\n\n        Exclusion Criteria:\n\n          -  Pharmacological treatment; diabetes and blood lipid regulation\n\n          -  Lactating (or lactating, 6 weeks ago), pregnant (or pregnant, 3 months ago) or wish\n             to become pregnant during the study\n\n          -  Participation in another biomedical trial 1 month prior to study start\n\n          -  Diagnosed with any form of diabetes, celiac disease or chronic pancreatitis\n\n          -  Reported chronic gastrointestinal disorders\n\n          -  Antibiotic treatment for 3 month prior to study start\n\n          -  Blood hemoglobin < 7.0 mmol/l\n\n          -  Blood donation within 1 month prior to study start"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01719913", 
            "org_study_id": "NNF-CBMR 3861-34275"
        }, 
        "intervention": [
            {
                "arm_group_label": "High gluten", 
                "description": "Refined grain/ gluten rich diet : Participants consume more than 25g of gluten per day (estimated to correspond to a gluten intake around the 90th percentile in the population)", 
                "intervention_name": "High gluten", 
                "intervention_type": "Other", 
                "other_name": "High gluten"
            }, 
            {
                "arm_group_label": "Low gluten", 
                "description": "Poor gluten diet: Participants consume less than 5g gluten per day (estimated to correspond to a gluten intake below the 10th percentile in the population)", 
                "intervention_name": "Low gluten", 
                "intervention_type": "Other", 
                "other_name": "Low gluten"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 4, 2013", 
        "link": {
            "url": "http://www.3g-center.dk/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "The Novo Nordisk Foundation of Basic Metabolic Health, Section for Metabolic Genetics"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Gut, Grain and Greens (3G): The Effect of Gluten on Gut Microbiome and Metabolic Health.", 
        "other_outcome": [
            {
                "description": "Validated method for dietary registration, based on 2 week and 2 weekend days.", 
                "measure": "4 days precoded food diary.", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "Changes from baseline to after intervention in individual gastrointestinal symptoms by validated VAS-questionary.", 
                "measure": "Gastrointestinal symptoms.", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }
        ], 
        "overall_official": {
            "affiliation": "University of Copenhagen", 
            "last_name": "Oluf B Pedersen, MD, DMSCi,Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Feces samples are collected according to standard operation procedures for subsequent standardized microbial DNA extraction. Microbial DNA will be subjected to sequencing, microbial gene analyses, taxonomy analyses including enterotypes known species and unknown meta-species and functional annotation.", 
            "measure": "Altered quantitative metagenomics at bacterial gene- and species levels.", 
            "safety_issue": "No", 
            "time_frame": "Up to 3 years."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01719913"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Copenhagen", 
            "investigator_full_name": "Oluf Borbye Pedersen", 
            "investigator_title": "Scientific Director, professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Participants are instructed in swallowing capsules containing different small non-invasive and non-absorbable plastic pellets for 6 consecutive days. On the seventh day they are having an X-ray of the abdomen taken.", 
                "measure": "Mean intestinal transit time", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "Lactulose/mannitol ratio in urine after four hours collection following oral intake of lactulose and mannitol.", 
                "measure": "Gastrointestinal permeability.", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "Breath hydrogen after intake of standardized breakfast (30,60,90,120,180 minutes)", 
                "measure": "Colonic fermentation", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "Systolic and diastolic blood pressure and heart beat rate are measured after 10 min of rest according to current standard operational procedure with an automatic blood pressure meter. Participants are instructed not to talk during the measurements.", 
                "measure": "Blood pressure and pulse.", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year."
            }, 
            {
                "description": "Saliva is collected after the participants have taken a small piece of paraffin in their mouth and have chewed until the paraffin has turned into one coherent mass (approximately one minute). Participants are swallowing the produced saliva for that minute. After this, and for the next 3 minutes, saliva is collected in a cup and handed over to the study personnel. Saliva is stored at minus 80 degrees for later studies of saliva microbial flora and saliva biochemistry.", 
                "measure": "Saliva microbial flora", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "Nasal fluid is collected by a non-invasive methodology for in vivo measurement of an array of immunological signalling molecules in the nasal airway lining. The method is based on a standardized collection of mucosal airway fluid from both nostrils onto small sheets of filter papers with efficient absorption properties. The technique is highly reproducible, and used for measuring immunological mediators representing the immediate response ability of the mucosal immune system.", 
                "measure": "Nasal fluid", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 years."
            }, 
            {
                "description": "Glucagon like peptide 1 and 2, Gastric inhibitory polypeptide, peptide YY and Ghrelin.", 
                "measure": "Appetite hormones", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 years."
            }, 
            {
                "description": "Levels of gliadin and Immunoglobulin A and G transglutaminase.", 
                "measure": "Celiac disease markers", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year."
            }, 
            {
                "description": "Low density Lipoproteins, High density lipoproteins, Total Cholesterol, Very low density lipoproteins and Free fatty acids.", 
                "measure": "Blood lipid profile", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "Body composition (lean body mass and fat mass) is measured by bio-electrical impedance using multi frequency Quadscan.", 
                "measure": "Bioimpedance", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year."
            }, 
            {
                "description": "Breath hydrogen measurements are done before the intake of the standardized breakfast (at 30, 60, 90, 120, 180 minutes), as an indicator of colonic fermentation.", 
                "measure": "Breath hydrogen.", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "Fasting insulin and post prandial at 30, 60, 90, 120 and 180 minutes after standardized meal.", 
                "measure": "Insulin", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "Fasting glucose and post prandial at 30, 60, 90, 120 and 180 minutes after standardized meal.", 
                "measure": "Glucose", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "Fasting.", 
                "measure": "C-peptide", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years."
            }, 
            {
                "description": "High sensitive C-reactive protein, Interleukin 1, 6 and 10, Lipopolysaccharide- binding protein, Tumor necrosis factor - alfa.", 
                "measure": "Inflammatory makers", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 years."
            }, 
            {
                "description": "Weight, height, sagittal height and waist circumference.", 
                "measure": "Anthropometric characteristics.", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year."
            }
        ], 
        "source": "University of Copenhagen", 
        "sponsors": {
            "collaborator": {
                "agency": "Technical University of Denmark", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}